| Image 1: A reasonable carb intake, regular exercise and, interestingly, creatine will help you not to become insulin resistant in the first place. |
A teaspoon of creatine a day keeps metformin away!
In the latest issue of the journal Amino Acids Christiano Robles Rodrigues Alves and his colleagues from the School of Physical Education and Sports at the University of Sao Paulo in (guess where ;-) Sao Paulo, Brazil, present the results of a double-blind randomized controlled trial involving "25 non-vegetarian type 2 diabetic patients", who received either 5g/day creatine monohydrate or placebo for 12 weeks. In addition, the obese (BMI: 32.5kg/m²) men and women had to take part in a twice-weekly exercise regimen, of which I assume that it revolved around relatively light cardiovascular type of exercises, because otherwise the scientists would probably have provided some more details on what exactly the subjects did.
| Figure 1: Macronutrient composition (in g) of the (ad-libitum) diets of the study participants at the beginning and end of the 12-week creatine/placebo + exercise intervention (data adapted from Alves. 2012) |
| Figure 2: Changes in AMPK-alpha expression (left) and changes in Hb1Ac expressed as a function of changes in AMPK-alpha in the creatine group (right; data adapted from Alves. 2012) |
Hah? Doesn't creatine increase energy stores? How come it does increase AMPK, then?
As a diligent student of the SuppVersity you will have read about the creatine-induced increases in AMPK-alpha expression before (cf. "A Glimpse on Other AMPK Modulators"). Some of you may also have read the Bernado's question, how creatine, a supplement that is marketed for its ability to raise intra-cellular energy stores decreases AMPK, when the latter is the energy sensor of the cell. And in fact, this does sound somewhat counterintuitive at first, but if you think about "how" exactly creatine works, it makes perfect sense.
Note: It is somewhat unfortunate that the scientists did control which of the two AMPK-alpha isoforms (alpha-1 or alpha-2, cf. "AMPK Isoforms") were elevated in response to the creatine (+ "exercise") intervention. In view of the fact that the alpha-2 isoform appears to prevail in skeletal muscle, we may yet assume that those elevations in AMPK did probably not exert any direct negative effects on mTOR and subsequently the protein synthetic response to exercise - the fact that both AKT and MAPK expression were identical in both groups would support this notion.
Supplemental creatine (as monohydrate or whatever other form) has to be "phosphorylated" (bound to a phosphor molecule) by the creatine kinase enzyme to form the rapidly mobilizable energy reserve, of which you all know that it can help you to lift heavier and think faster (don't disregard the importance of creatine for bain health, cf. "Creatine for Brain Health")! The energy that is necessary to convert the unphosphorylated supplemental creatine molecules, as well as the phosphates that are necessary to "recycle" the used PCr (now likewise unphosphorylated creatine molecules) is derived from intramuscular ATP. This leaves us with a bunch of newly "energized" phosphocreatine (PCr) molecules and a similar amount of adenosine-di-phospate (ADP) molecules, the presence of which in the muscle has been identified as the main factor, which protects AMPK from dephosphorylation (= being active) and thusly facilitates all the beneficial down-stream effects on glucose uptake (most prominently an increased expression and translocation of the GLUT-4 glucose transporters on the cell membrane), the medical orthodoxy still believes to be an exclusive prerogative of biguanide based diabetes drugs such as metformin (Glucophage).Wait! Does creatine hamper my gains then?
With AMPK being the opponent of the "muscle-building" mTOR complex, these results could suggest that taking creatine may actually blunt protein synthesis. Now, while that may be the case, if you let your muscles starve for glucose, the opposite will be the case when, there is enough muscle glycogen to replenish both, the ATP as well as the PCr stores, since more PCr will translate into increased workloads and those will in turn provide a more pronounced growth stimulus, which will then result in creatine's well-established multiplicative effects of creatine on exercise-induced skeletal muscle hypertrophy (Hespel. 2007).
To make everything clear, creatine needs ATP to become PCr therefore reducing the amount of ATP and inducing AMPK. And as far as I remember our body uses the PCr to restore ATP once it is depleted?
ReplyDeleteIsn't that a bit like a vicious circle?
And one more question that I just have to ask, when would you use you creatine in the AMPK/mTOR SeeSaw? At the end of AMPK, at the end of mTOR or somewhere in between mTOR?
@Pawel: It would be / become viscous when there was no glycogen to replenish the ATP stores "from outside the circle"... PCr is quasi an "afterburner" that is filled with compressed gas from the tank and can reinject the gas at a high speed, whenever you need it. Now that does obviously not mean that you would not have to refuel, when the energy from the ATP (regular tank) and PCr are exhausted.
ReplyDeleteIf you want to increase AMPK, you would obviously take creatine without glucose so that the ATP will be used to replete the PCr... but in essence, I don't believe that it will make a significant difference, when you take it
seems to me that the safest solution would be to use it post-workout with a proper dosage of carbs (or carbs+Whey). No chances of increasing AMPK as the decrease of ATP would be reloaded by incoming CARBS. SO in fact the old "Bro-Science" to take creatine with carbs makes perfect sense, but not because of "insulin spiking creatine transporting" reasons, but to reloaded your ATP.
ReplyDeleteI, for one, always like seeing data plotted for individual subjects.
ReplyDeleteIs the trendline in Figure 2 plotted by software? I think it's debatable as to which subject is the outlier there.
speak of the devil:
ReplyDelete"FDA Adds Diabetes Warning to Statin Label"
http://www.medpagetoday.com/PublicHealthPolicy/PublicHealth/31406#
"...to include a warning about an increased risk of hyperglycemia and transient memory problems, but the agency is no longer recommending routine liver function testing."